Total Payments
$6,168
2024 Payments
$2,803
Companies
33
Transactions
260
Medicare Patients
4,448
Medicare Billing
$342,023
Payment Breakdown by Category
Food & Beverage$5,803 (94.1%)
Education$364.90 (5.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,803 | 254 | 94.1% |
| Education | $364.90 | 6 | 5.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $603.78 | 23 | $0 (2024) |
| Amgen Inc. | $588.02 | 24 | $0 (2024) |
| ABBVIE INC. | $583.10 | 29 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $549.64 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $442.69 | 16 | $0 (2024) |
| GENZYME CORPORATION | $390.31 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $364.50 | 18 | $0 (2024) |
| Janssen Biotech, Inc. | $362.75 | 15 | $0 (2024) |
| Incyte Corporation | $321.83 | 15 | $0 (2023) |
| UCB, Inc. | $261.30 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,803 | 123 | E.R. Squibb & Sons, L.L.C. ($354.10) |
| 2023 | $1,996 | 77 | Lilly USA, LLC ($292.81) |
| 2022 | $1,186 | 52 | Incyte Corporation ($177.83) |
| 2021 | $183.34 | 8 | AbbVie Inc. ($96.59) |
All Payment Transactions
260 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $32.88 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $37.36 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Krystal Biotech Inc | VYJUVEK (Drug) | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Immunology | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $33.57 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Immunology | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $30.14 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $58.46 | General |
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $19.17 | General |
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $27.65 | General |
| Category: Immunology | ||||||
| 10/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Inflammation | ||||||
| 10/25/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $31.18 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,933 | 8,879 | $389,137 | $152,650 |
| 2022 | 18 | 1,704 | 9,816 | $334,210 | $135,108 |
| 2021 | 12 | 811 | 1,229 | $121,500 | $54,265 |
Total Patients
4,448
Total Services
19,924
Medicare Billing
$342,023
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 417 | 532 | $66,500 | $30,768 | 46.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 202 | 304 | $53,200 | $25,194 | 47.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 198 | 237 | $42,660 | $18,288 | 42.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 274 | 349 | $44,323 | $12,225 | 27.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 163 | 188 | $39,480 | $11,263 | 28.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $17,395 | $8,017 | 46.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 118 | 118 | $18,880 | $7,923 | 42.0% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 21 | 5,800 | $12,470 | $7,527 | 60.4% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2023 | 23 | 33 | $13,035 | $5,481 | 42.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 201 | 946 | $22,704 | $4,434 | 19.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 25 | 33 | $13,596 | $4,021 | 29.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 17 | 17 | $7,259 | $3,751 | 51.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 31 | 31 | $8,153 | $2,976 | 36.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 23 | 23 | $8,418 | $2,178 | 25.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 15 | $4,050 | $1,843 | 45.5% |
| 10040 | Acne surgery | Office | 2023 | 22 | 22 | $3,938 | $1,765 | 44.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 40 | 46 | $5,290 | $1,667 | 31.5% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 12 | $2,592 | $1,244 | 48.0% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 21 | 22 | $3,410 | $1,046 | 30.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 24 | $1,560 | $989.46 | 63.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 18 | 56 | $224.00 | $47.47 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 215 | 297 | $51,800 | $26,325 | 50.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 337 | 424 | $52,475 | $24,656 | 47.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 151 | 171 | $30,780 | $13,518 | 43.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 284 | 365 | $46,355 | $13,198 | 28.5% |
About Dr. Danielle Brown, MD
Dr. Danielle Brown, MD is a Pediatric Dermatology healthcare provider based in New Braunfels, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2016. The National Provider Identifier (NPI) number assigned to this provider is 1952750267.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danielle Brown, MD has received a total of $6,168 in payments from pharmaceutical and medical device companies, with $2,803 received in 2024. These payments were reported across 260 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,803).
As a Medicare-enrolled provider, Brown has provided services to 4,448 Medicare beneficiaries, totaling 19,924 services with total Medicare billing of $342,023. Data is available for 3 years (2021–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatric Dermatology
- Other Specialties Dermatology
- Location New Braunfels, TX
- Active Since 06/07/2016
- Last Updated 08/26/2025
- Taxonomy Code 207NP0225X
- Entity Type Individual
- NPI Number 1952750267
Products in Payments
- DUPIXENT (Biological) $961.34
- Otezla (Drug) $561.12
- TALTZ (Drug) $507.30
- SKYRIZI (Biological) $464.26
- Sotyktu (Drug) $442.69
- TREMFYA (Drug) $362.75
- OPZELURA (Drug) $321.83
- OCTRODE (Device) $197.38
- Bimzelx (Biological) $185.91
- COSENTYX (Biological) $176.56
- Zoryve (Drug) $168.98
- COSENTYX (Drug) $167.00
- KYPHON EXPRESS II KYPHOPAK TRAY (Device) $130.59
- ILUMYA (Biological) $116.90
- VYJUVEK (Drug) $104.43
- ACTHAR (Biological) $90.07
- VENASEAL (Device) $84.76
- VTAMA (Drug) $84.31
- Cimzia (Drug) $75.39
- HUMIRA (Biological) $64.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.